A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
Active, not recruiting · NCT04540900 · Registry updated 2025-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions | Fine Lines; Skin Roughness; Skin Thickness; Wrinkle | Active, not recruiting | Phase 1 | 2025-05-13 | NCT04540900 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Krystal Biotech, Inc. | 11 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aesthetx | Campbell | United States | 1 |
| Mission Dermatology | Rancho Santa Margarita | United States | 2 |
| Skin and Cancer Associates, LLP. D/B/A Center for Clinical and Cosmetic Research | Aventura | United States | 1 |
| Steve Yoelin, MD Medical Associates, Inc. | Newport Beach | United States | 1 |